KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,918,941 | -8.4% | 218,339 | +17.5% | 0.01% | -8.3% |
| Q2 2023 | $40,288,778 | -11.7% | 185,791 | -26.0% | 0.01% | -14.3% |
| Q1 2023 | $45,607,624 | +0.4% | 251,088 | +8.7% | 0.01% | -6.7% |
| Q4 2022 | $45,404,665 | -7.2% | 231,067 | +6.2% | 0.02% | -16.7% |
| Q3 2022 | $48,926,000 | +125.7% | 217,515 | +26.9% | 0.02% | +125.0% |
| Q2 2022 | $21,678,000 | +6.6% | 171,347 | +6.8% | 0.01% | +33.3% |
| Q1 2022 | $20,336,000 | -0.5% | 160,391 | +2.8% | 0.01% | 0.0% |
| Q4 2021 | $20,444,000 | +9.3% | 156,059 | +2.1% | 0.01% | 0.0% |
| Q3 2021 | $18,701,000 | +19.6% | 152,873 | +11.4% | 0.01% | +20.0% |
| Q2 2021 | $15,642,000 | +7.6% | 137,216 | +13.5% | 0.01% | 0.0% |
| Q1 2021 | $14,531,000 | +33.5% | 120,857 | +12.8% | 0.01% | +25.0% |
| Q4 2020 | $10,888,000 | +33.5% | 107,172 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $8,154,000 | -9.0% | 105,453 | +31.2% | 0.00% | 0.0% |
| Q2 2020 | $8,958,000 | +90.2% | 80,363 | +22.9% | 0.00% | +33.3% |
| Q1 2020 | $4,710,000 | +43.4% | 65,406 | +50.1% | 0.00% | +50.0% |
| Q4 2019 | $3,284,000 | +523.1% | 43,584 | +35.1% | 0.00% | – |
| Q3 2019 | $527,000 | – | 32,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |